FDA Import Refusal 231-4226207-7/11/1 — Intas Pharmaceuticals Limited
The FDA refused shipment 231-4226207-7/11/1 from Intas Pharmaceuticals Limited (India) on Jan 17, 2025. The refused product falls under Drugs and Biologics — GEMCITABINE HCL (ANTI-NEOPLASTIC). Cited charge: 27 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jan 17, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62IIY80 GEMCITABINE HCL (ANTI-NEOPLASTIC)
- Charges
- 27